Advancing a Prognostic Biomarker Panel for Pediatric Crohn’s Disease with Genedata Profiler
Predicting potential future complications and response to treatment in pediatric Crohn’s disease patients using biomarkers will help provide optimal care and improve healthcare outcomes.
Learn how Genedata Profiler allow you to unlock insights from high-dimensional multi-omics data to identify such biomarkers.
In this webinar, the non-profit organization dedicated to curing IBD (Inflammatory Bowel Disease) shares its latest progress in its ongoing research and development activities. During his presentation, Dr. Andrés Hurtado-Lorenzo, VP of Translational Research and IBD Ventures at the Crohn’s & Colitis Foundation, will present:
- How Genedata Profiler enables advanced analytical approaches such as machine learning to discover prognostic gene and protein expression signatures, and
- Some results generated using a custom biomarker panel that was developed from these approaches, elucidating its utility as a clinical tool for early prognosis of disease course in pediatric Crohn’s disease
Who should watch it?
Biopharma and biotech professionals working in translational research looking to identify biomarkers through analyzing multi-omic data from different drug development stages to guide the treatment of patients with complex diseases.
Speaker: Dr. Andrés Hurtado-Lorenzo, Vice President of Translational Research and IBD Ventures at the Crohn’s & Colitis Foundation